RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Holders of 5% or more of RVLP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of RVL Pharmaceuticals plc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of RVL Pharmaceuticals plc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on RVL Pharmaceuticals plc, newest first.
No Schedule 13D or 13G filings on RVL Pharmaceuticals plc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell RVL Pharmaceuticals plc shares.
No Form 144 notices for RVL Pharmaceuticals plc are on file.